Survival and secondary interventions following treatment for locally-advanced prostate cancer.
Rachael D. Sussman(Georgetown University), Keith Kowalczyk, Choayi Zheng(Georgetown University), Andrew Harbin(Georgetown University), Stephen B. Williams(Cedars-Sinai Medical Center), Lambros Stamatakis(MedStar Washington Hospital Center), John H. Lynch(Georgetown University), Jim C. Hu(Presbyterian Hospital), Jonathan Hwang(MedStar Washington Hospital Center), Filipe L.F. Carvalho(Brigham and Women's Hospital)
PubMed
October 1, 2018
Cited by 3
Related Papers
Impaired nitric oxide-mediated vasodilation in patients with non-insulin-dependent diabetes mellitus
|Journal of the American College of Cardiology|1996|1k
Acute Hyperglycemia Attenuates Endothelium-Dependent Vasodilation in Humans In Vivo
|Circulation|1998|804
Formation of Toxic Oligomeric α-Synuclein Species in Living Cells
|PLoS ONE|2008|410
Epidemiology, Screening, and Prevention of Bladder Cancer
|European Urology Oncology|2022|361
What Is the Significance of Variant Histology in Urothelial Carcinoma?
|European Urology Focus|2019|251